Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 269-275

  Li, Ping ^a   Cao, Jie ^a   Chen, Yifei ^a   Wang, Wei ^a   Yang, Jiong ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Adenosine 5' triphosphate; Allergic asthma; Apyrase; CD39; Dendritic cells

Indexed keywords

ALUMINUM HYDROXIDE; APYRASE; CD39 ANTIGEN; MESSENGER RNA; OVALBUMIN; TRANSCRIPTION FACTOR GATA 3; ADENOSINE TRIPHOSPHATE; ANTIASTHMATIC AGENT; CYTOKINE; GATA3 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; WESTERN BLOTTING; ANIMAL; ASTHMA; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CHEMISTRY; CHICKEN; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LUNG; PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ALUMINUM HYDROXIDE; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIGENS, CD; APYRASE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CHEMOTAXIS; CHICKENS; CYTOKINES; DENDRITIC CELLS; EPITHELIAL CELLS; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; LUNG; MICE; MICE, INBRED C57BL; OVALBUMIN; SIGNAL TRANSDUCTION;

EID: 84902677064     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1771     Document Type: Article

References (34)

1. Lloyd CM and Hessel EM: Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immun 10: 838-848, 2010.
2. Adcock IM, Caramori G and Chung KF: New targets for drug development in asthma. Lancet 372: 1073-1087, 2008.
3. Holgate ST and Polosa R: Treatment strategies for allergy and asthma. Nat Rev Immunol 8: 218-230, 2008. (Pubitemid 351323290)
4. Lambrecht BN and Hammad H: Biology of lung dendritic cells at the origin of asthma. Immunity 31: 412-424, 2009.
5. Kim HY, DeKruyff RH and Umetsu DT: The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 11: 577-584, 2010.
6. Trautmann A: Extracellular ATP in the immune system: more than just a 'danger signal'. Sci signal 2: pe6, 2009.
7. Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K and Enjyoji K: Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 31: 217-233, 2005. (Pubitemid 40605196)
8. Idzko M, Hammad H, van Nimwegen M, et al: Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13: 913-919, 2007. (Pubitemid 47222044)
9. Müller T, Robaye B, Vieira RP, et al: The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 65: 1545-1553, 2010.
10. Müller T, Vieira RP, Grimm M, et al: A potential role for P2X7R in allergic airway inflammation in mice and humans. Am J Respir Cell Mol Biol 44: 456-464, 2011.
11. Manthei DM, Jackson DJ, Evans MD, et al: Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function. J Allergy Clin Immunol 130: 496-502, 2012.
12. Crikis S, Lu B, Murray-Segal LM, et al: Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant 10: 2586-2595, 2010.
13. Künzli BM, Berberat PO, Dwyer K, et al: Variable impact of CD39 in experimental murine colitis. Dig Dis Sci 56: 1393-1403, 2011.
14. Künzli BM, Nuhn P, Enjyoji K, et al: Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Gastroenterology 134: 292-305, 2008. (Pubitemid 350309325)
15. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB and Robson SC: CD39 and control of cellular immune responses. Purinergic Signal 3: 171-180, 2007.
16. Deaglio S and Robson SC: Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 61: 301-332, 2011.
17. Antonioli L, Pacher P, Vizi ES and Haskó G: CD39 and CD73 in immunity and inflammation. Trends Mol Med 19: 355-367, 2013.
18. Kwak YG, Song CH, Yi HK, et al: Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 111: 1083-1092, 2003. (Pubitemid 36397485)
19. Idzko M, Dichmann S, Ferrari D, et al: Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100: 925-932, 2002. (Pubitemid 34832619)
20. Enjyoji K, Sévigny J, Lin Y, et al : Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5: 1010-1017, 1999. (Pubitemid 29439571)
21. Kapojos JJ, van den Berg A, Borghuis T, et al: Enhanced ecto-apyrase activity of stimulated endothelial or mesangial cells is downregulated by glucocorticoids in vitro. Eur J Pharmacol 501: 191-198, 2004. (Pubitemid 39298952)
22. Heine P, Braun N, Sévigny J, Robson SC, Servos J and Zimmermann H: The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2. Eur J Biochem 268: 364-373, 2001. (Pubitemid 32862667)
23. Paletta-Silva R and Meyer-Fernandes JR: Adenosine and immune imbalance in visceral leishmaniasis: the possible role of ectonucleotidases. J Trop Med 2012: 650874, 2012.
24. Souza Vdo C, Schlemmer KB, Noal CB, et al: E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease. Parasitol Int 61: 690-696, 2012.
25. Fan J, Zhang Y, Chuang-Smith ON, et al: Ecto-5'-nucleotidase: a candidate virulence factor in Streptococcus sanguinis experimental endocarditis. PloS One 7: e38059, 2012.
26. Théâtre E, Frederix K, Guilmain W, et al: Overexpression of CD39 in mouse airways promotes bacteria-induced inflammation. J Immunol 189: 1966-1974, 2012.
27. + regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 183: 7602-7610, 2009.
28. Moncrieffe H, Nistala K, Kamhieh Y, et al: High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 185: 134-143, 2010.
29. Peelen E, Damoiseaux J, Smolders J, et al: Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. J Íeuroimmunol 240-241: 97-103, 2011.
30. Hart ML, Gorzolla IC, Schittenhelm J, Robson SC and Eltzschig HK: SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol 184: 4017-4024, 2010.
31. Bönner F, Borg N, Burghoff S and Schrader J: Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. PloS One 7: e34730, 2012.
32. Friedman DJ, Künzli BM, A-Rahim YI, et al: CD39 deletion exacerbates experimental murine colitis and human polymor?phisms increase susceptibility to inflammatory bowel disease. Proc Nat Acad Sci USA 106: 16788-16793, 2009.
33. Chen X, Gao YD and Yang J: Elevated interferon regulatory factor 4 levels in patients with allergic asthma. J Asthma 49: 441-449, 2012.
34. Stellato C, Gubin MM, Magee JD, et al: Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR. J Immunol 187: 441-449, 2001.